Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Haak

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Diabetes Technology & Therapeutics|August 22, 2008
Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical settingNorbert Hermanns, Bernhard Kulzer, Thomas Haak
Diabetes Technology & Therapeutics|February 12, 2008
The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practiceStephan A Schreiber, Klaus Ferlinz, Thomas Haak
Diabetes Care|August 30, 2007
Clinical depression versus distress among patients with type 2 diabetes: not just a question of semanticsNorbert Hermanns, Thomas Kubiak, Berndhard Kulzer, et al.
Journal of Carcinogenesis|September 28, 2007
The association between paternal prostate cancer and type 2 diabetesPeter Meyer, Christine Zuern, Norbert Hermanns, et al.
Journal of Diabetes Science and Technology|May 31, 2014
The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trialNorbert Hermanns, Beatrix Schumann, Bernhard Kulzer, et al.
Clinical Therapeutics|July 10, 2007
Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label studyThomas Haak, Steven Edelman, Claudia Walter, et al.
Patient Education and Counseling|July 1, 2011
The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetesNorbert Hermanns, Bernhard Kulzer, Berthold Maier, et al.
Diabetes Care|June 11, 2009
Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomesBernhard Kulzer, Norbert Hermanns, Daniela Gorges, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 12, 2025
Diabetes in HospitalsKarsten Müssig, Baptist Gallwitz, Thomas Haak, et al.
Psychotherapy and Psychosomatics|May 8, 2022
Diabetes Distress and Depression during COVID-19: Response to Breznoscakova et al. Uncovering the Untold Emotional Toll of Living with Diabetes in the COVID-19 EraAndreas Schmitt, Bernhard Kulzer, Dominic Ehrmann, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Diabetes Technology & Therapeutics|August 22, 2008
Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical settingNorbert Hermanns, Bernhard Kulzer, Thomas Haak
Diabetes Technology & Therapeutics|February 12, 2008
The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practiceStephan A Schreiber, Klaus Ferlinz, Thomas Haak
Diabetes Care|August 30, 2007
Clinical depression versus distress among patients with type 2 diabetes: not just a question of semanticsNorbert Hermanns, Thomas Kubiak, Berndhard Kulzer, et al.
Journal of Carcinogenesis|September 28, 2007
The association between paternal prostate cancer and type 2 diabetesPeter Meyer, Christine Zuern, Norbert Hermanns, et al.
Journal of Diabetes Science and Technology|May 31, 2014
The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trialNorbert Hermanns, Beatrix Schumann, Bernhard Kulzer, et al.
Clinical Therapeutics|July 10, 2007
Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label studyThomas Haak, Steven Edelman, Claudia Walter, et al.
Patient Education and Counseling|July 1, 2011
The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetesNorbert Hermanns, Bernhard Kulzer, Berthold Maier, et al.
Diabetes Care|June 11, 2009
Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomesBernhard Kulzer, Norbert Hermanns, Daniela Gorges, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 12, 2025
Diabetes in HospitalsKarsten Müssig, Baptist Gallwitz, Thomas Haak, et al.
Psychotherapy and Psychosomatics|May 8, 2022
Diabetes Distress and Depression during COVID-19: Response to Breznoscakova et al. Uncovering the Untold Emotional Toll of Living with Diabetes in the COVID-19 EraAndreas Schmitt, Bernhard Kulzer, Dominic Ehrmann, et al.
Pageof 10